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Abstract
Objectives To evaluate diagnostic imaging costs before and
after DTS implementation in patients with suspected thoracic
lesions on CXR.
Methods Four hundred sixty-five patients (263 male, 202
female; age, 72.47±11.33 years) with suspected thoracic le-
sion(s) after CXR underwent DTS. Each patient underwent
CT when a pulmonary non-calcified lesion was identified by
DTS while CT was not performed when a benign pulmonary
or extrapulmonary lesion or pseudolesion was identified. The
average per-patient imaging cost was calculated by normalis-
ing the costs before and after DTS implementation.
Results In 229/465 patients who underwent DTS after suspi-
cious CXR, DTS showed 193 pulmonary lesions and 36 pleural
lesions, while in the remaining 236/465 patients, lesions were
ruled out as pseudolesions of CXR. Chest CT examination
was performed in 127/465 (27 %) patients while in the re-
maining 338/465 patients (73 %) CXR doubtful findings were
resolved by DTS. The average per-patient costs of CXR, DTS
and CT were €15.15, 41.55 and 113.66. DTS allowed an
annual cost saving of €8,090.2 considering unenhanced CT
and €19,298.12 considering contrast-enhanced CT. Considering
a DTS reimbursement rate of € 62.7 the break even point
corresponds to 479 DTS examinations.
Conclusion Per-patient diagnostic imaging costs decreased after
DTS implementation in patients with suspected thoracic lesions.
Main Messages
• Digital tomosynthesis improves the diagnostic accuracy and
confidence in chest radiography
• Digital tomosynthesis reduces the need for CT for a
suspected pulmonary lesion
• Digital tomosynthesis requires a dose level equivalent to
that of around two chest radiographies
• Digital tomosynthesis produces a significant per-patient
saving in diagnostic imaging costs







The detection and characterisation of pulmonary lesions, and
particularly of pulmonary nodules, are challenging tasks on
chest radiography (CXR) because of their frequently small
size and poor conspicuity within surrounding anatomical
structures. Pulmonary lesions are often visible only retrospec-
tively when reviewing previous radiographic images of pa-
tients with known nodules [1], and computer-aided detection
systems have been advocated to improve the diagnostic accu-
racy [2]. Frequently, the radiologist reporting CXR identifies
doubtful or equivocal findings that could be referred to as both
pulmonary and extra-pulmonary lesions or also as pulmonary
pseudolesions because of different planes overlapping or com-
posite areas of increased opacity.
E. Quaia (*) : E. Baratella :R. Cuttin :G. Poillucci : S. Kus :
M. A. Cova
Department of Radiology, Cattinara Hospital, University of Trieste,
Strada di Fiume 447, 34149 Trieste, Italy
e-mail: quaia@units.it
G. Grisi
Department of Economics and Mathematical Sciences, University of
Trieste, Piazzale Europa 1, 34127 Trieste, Italy
Insights Imaging (2014) 5:147–155
DOI 10.1007/s13244-013-0305-1
Even though oblique radiographic views are still frequently
employed, computed tomography (CT) is the gold standard for
imaging pulmonary lesions, in particular pulmonary nodules
[3, 4]. However, it is relatively expensive, delivers a consider-
able radiation dose to the patient and the diagnosis time can also
be longer because of CT unit work overload. Therefore, CXR
remains the initial examination for detecting most lung lesions,
with CT being normally used to confirm the diagnosis in
doubtful cases. As such, CT is frequently performed in patients
without any pulmonary lesions or with pulmonary lesions that
appear clearly benign or extra-pulmonary after CT [1, 3, 4].
Digital tomosynthesis (DTS) [5, 6] is a tomographic tech-
nique like CT, but delivers a lower radiation dose [5–8]. DTS is
easily implemented in conjunction with CXR as it employs the
sameX-ray equipment. Unlike conventional tomography, DTS
is not limited to reconstruction of a single plane, but can
generate an arbitrary number of slice planes orthogonal to the
projection direction. Reconstruction of the image planes is
performed from a set of projection data acquired over a limited
angle range of a single X-ray tube. A series of projection
radiographs are acquired during the X-ray tube movement,
and, due to the parallax effect, the anatomy at different depths
in the patient can be mapped by the projections. These projec-
tions are then shifted and added to bring into focus objects in a
given plane. By varying the amount of shift, planar images at
different depths can be reconstructed [7–9], and objects outside
of the focus plane are rendered with a varying amount of blur.
Previous studies have shown that DTS vs. CXR improved
sensitivity in the detection of CT-proven lung nodules [7–10]
and that DTS provides high diagnostic accuracy and confi-
dence in confirming or ruling out pulmonary lesions suspected
on CXR by improving pulmonary lesion conspicuity [11–14].
According to these results DTS could be considered a problem-
solving technique in patients with suspected pulmonary lesions
on CXR and could be used in the place of CT in this particular
clinical setting. Cost analyses on different alternative diagnostic
processes represent a valuable alternative for focussed cost
reductions, instead of proportional fund reduction, and an
opportunity for the measurement of the outcome of the diag-
nostic and therapeutic processes [15–18]. However, no previ-
ous studies have evaluated the actual impact in diagnostic
imaging costs before and after DTS implementation.
The aim of this study was to evaluate diagnostic imaging
costs before and after DTS implementation in patients with
suspected thoracic lesions on CXR.
Methods and materials
Patients
This was a single-centre prospective study, approved by the
ethics committee of our hospital, and informed consent was
obtained from all patients after the nature of the procedure had
been fully explained. From June 2007 to March 2012, all
patients who revealed suspected pulmonary lesion(s)
appearing as areas of increased opacity or pulmonary nodules
[19] on CXR underwent DTS. CXR was obtained in the
upright postero-anterior and left lateral views, and the prelim-
inary CXR interpretation was performed on screen by two
board-certified diagnostic radiologists affiliated to our depart-
ment and respectively with 10 and 25 years of experience in
thoracic imaging. Suspected pulmonary lesions were those
that could not reliably be considered present or located within
the lung, based only on CXR interpretation.
Eligibility criteria for the present study were: DTS per-
formed within 15 days after CXR and absence of respiratory
artefacts onDTS images preventing correct image assessment.
Of the 506 patients who were deemed initially eligible for the
study, 41 were excluded for the following reasons: (1) the
patients had had previous chest surgery (n=5); (2) the patients
had subdiagnostic DTS images because of the inability to
keep the upright position or suspend respiration (n=7); (3)
loss of patients’ information or incomplete patient follow-up
(n=29). Therefore, we finally included 465 patients (mean age
72.47±11.33 years), who met the inclusion criteria including
263 men (mean age 71.48 years±10.58; median age 73 years;
age range 23–94 years) and 202 women (mean age
73.74 years±12.13; median age 74 years; age range 34–
97 years) and these patients were considered in the present
study.
Chest radiography
In each patient the CXR was obtained by a computed radiog-
raphy (KodakDirectView CR 975 System; Carestream, Roch-
ester, NY, USA) or digital radiography (Definium 8000; GE
Healthcare, Chalfont St Giles, UK). The X-ray tube had a
focal spot size of 0.6 mm, a wall stand, and stationary anti-
scatter grid (70 lines per cm; ratio 13:1).
Digital tomosynthesis
The radiographical system (Definium 8000; GE Healthcare,
Chalfont St Giles, UK) consisted of an X-ray tube (focal spot
size 0.6 mm), a wall stand, a stationary antiscatter grid (70
lines per cm; ratio 13:1) and a cesium iodide–amorphous
silicon (CsI/a-Si) indirect flat-panel detector (41×41 cm2;
200×200 μm2 pixel size). X-rays are converted to light in a
layer of thallium-doped CsI, then the light is converted to
electrical signals by a-Si photodiodes and the signal is
multiplexed to the readout electronics by thin-film transistors
(TFT) consisting of a-Si deposited on a glass substrate. The
signal is digitised with 14-bit resolution (16,384 grey levels)
by external electronics.
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We employed the VolumeRAD option of the digital X-ray
system, which acquires a series of very low-dose projection
images during a single linear sweep of the X-ray tube over an
angle of 30° with a stationary detector. A scout image is first
obtained to check the patient position. If the scout image is
satisfactory, the system calculates the appropriate low-dose
exposure (mAs) for DTS. Technique factors were: voltage 120
kVp; detector entrance dose, 0.5 μGy; nominal focal spot,
0.6 mm; additional copper filtration, 0.1 mm; breath-hold
acquisition time, 11 s; 60 low-dose projection images were
acquired at regular angular intervals during the tube sweep.
These data were then reconstructed with a filtered
backprojection algorithm to generate a set of images at a 5-
mm plane interval and a default number of slices depending
on patient size (41, 53 or 61 slices for a body mass index
<18.5, from 18.5 to 25 or >25, respectively). All projection
images were used for the reconstruction of each plane.
CT examination
CT of the chest was performed with a 64-row multi-detector
CT (Aquilion, Toshiba, Tokyo, Japan). Patients were
instructed to hold their breath with tidal inspiration during
scanning. Technical parameters were: rotation time 400 ms;
beam collimation 64×0.5 mm; normalised pitch 1; z-axis
coverage 32mm; reconstruction interval 0.3 mm; tube voltage
120 kVp; tube current (effective mAs) 180-250 mAs depend-
ing on patient size; field of view 40 cm2. Image reconstruction
was performed in a 25–35-cm display field of view, depending
on the patient’s body habitus. CTexaminations consisted of an
unenhanced scan followed by a vascular phase scan acquired
40 s after the intravenous bolus injection of iodinated contrast
material (Iomeron 350, Bracco, Milan, Italy; 120 ml; 350 mg
I/ml, 3 ml/s at 2 ml/kg followed by 50 ml of saline flush)
administered with a dual-syringe power injector (Stellant CT
injector, Medrad, Indianola, PA, USA) via a 20-gauge catheter
inserted into an antecubital vein.
CT images at standard lung window settings (window level
of -600 HU and window width of 2000 HU) were analysed
immediately after image acquisition by a consensus of two
senior radiologists with 8–15 years of experience in chest
imaging affiliated to the radiology department where the study
was performed but not involved in the visual interpretation of
CXR or DTS images. Readers were free to scroll CT images
and to employ coronal or sagittal reformations to measure the
largest diameter of each thoracic lesion in each plane.
Image analysis
Visual analysis of CXR and DTS images of each patient was
carried out within 7 days after DTS by the same two radiol-
ogists who performed the initial CXR assessment. Image
analysis was performed for patient care, and the CXR and
DTS images of each patient were examined consecutively in
the same reading session according to the routine diagnostic
work flow. During the image analysis both readers worked
independently and were aware of patient identification and
clinical history, but were blinded to the other imaging find-
ings. Readers were allowed to use processing tools such as
windowing, image contrast, adjustment or magnification and
to scroll the DTS images. All readings were performed on a
picture-archiving and communications system (PACS)-inte-
grated workstation by using a 19-inch thin-film transistor
liquid crystal display (TFT LCD) with a resolution of
2,560×1,600 pixels at a central location with calibration of
the luminance response. The first two cases, taken from the
465 cases included in the present study, were used for training
to familiarise the radiologist with the process.
Readers were asked to re-identify those findings on the
CXR images, which led each patient to undergo DTS. For
those patients (n=19) with more than one suspected pulmo-
nary lesion on CXR, the largest and most conspicuous finding
was considered as the marker lesion. Then, both readers were
asked to confirm or exclude the same finding on DTS images
and to express diagnostic confidence about lesion nature and
pulmonary or extra-pulmonary location according to the scor-
ing system reported on Table 1.
Patient clinical management
The patient diagnostic workup was planned based on the
readers’ confidence score for DTS images. Discrepant inter-
pretations from the reader-independent analysis that could
determine a potential change in the patient management were
resolved by consensus through the involvement of an addi-
tional reader with similar experience in thoracic imaging.
When DTS images were scored as 1 or 2, which is the
identification of definite or probable benign pulmonary or
extrapulmonary lesions or pulmonary pseudolesions, the im-
aging follow-up was perfomed by CXR, which was repeated
after a mean time of 6 months (time range 3-8 months) from
DTS. When DTS images were scored as 3, 4 or 5, which
defined indeterminate or probable or definite pulmonary le-
sions, patients underwent CT within 1 week.
Reference standards
When DTS images were scored as 1 or 2 (overt benign
pulmonary or extrapulmonary lesions or pseudolesions), each
patient underwent imaging follow-up consisting of a CXR
planned a mean of 6 months (range 3-8 months) after DTS.
Considering the imaging findings obtained by DTS, the im-
aging follow-up was stopped when CXR did not confirm any
pulmonary lesion or confirmed the presence of overt benign
pulmonary or extrapulmonary lesion.
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When DTS images were scored as 3, 4 or 5, patients
underwent contrast-enhanced CT within 1 week. All lesions
presenting overt malignant features at CT (irregular or spiculated
margins, pleural or vascular infiltrations) underwent surgical
resection (n=5 patients), while the remaining lesions were
characterised byCT follow-up performed at least 6months apart
for a minimal period of 2 years. All lesions were considered
benign if they contained fat or were calcified or subsequently
disappeared during imaging follow-up, or decreased or remained
unequivocally stable in size during serial examinations.
Those lesions appearing as ground-glass opacities on CT
and that did not disappear during CT follow-up underwent
CT-guided biopsies (n=5 patients).
Cost analysis
The observational time is from 1 January to 31 December
2012. We compared the unit full costs (€) of the different
imaging units. All costs were derived from the accounting
system of our hospital. All lead times and output measure-
ments are expressed as the mean of the observed data [20].
According to the unit costs of the different imaging modalities
we calculated the differential costs with and without DTS
implementation based on patient number. We considered all
the differential costs as the costs that would change if the
hospital would implement an imaging modality in place of
another imaging modality. In our case we compared an hos-
pital with CXR and DTS to a second scenario in which only
CXR and CT were available to image pulmonary lesions.
It is a reasonable assumption that the different imaging
modalities do not determine any change in the common costs
(such as administration, management and facility costs) and
do not influence the final result [15, 21]. For this reason we
considered only the long-term variable costs (personnel, de-
preciation, maintenance) besides the difference between the
short-term variable costs [22]. We have included: capacity
costs (personnel and fixed assets) and costs of non-capacity
factors (variable costs) such as drugs, disposable devices,
energy, prosthesis, etc. [15]. The utilisation cost of the fixed
assets (depreciation), the medical, technical and nursing per-
sonnel costs are considered as capacity costs that are related to
the specific activities through the mean lead times of use.
The personnel costs were calculated based on the medical,
technical and nursing wage costs. We considered the mean
wages based on the national contract, and the mean number of
working days and hours to obtain the mean daily cost for each
personnel category. The personnel costs were calculated based
also on the unit occupation time, which was recorded for each
patient and included the time for image reconstruction both for
DTS and CT.
Every unit cost for each imaging technique (CXR, DTS,
and CT) was computed on the basis of the lead times of
capacity resources (e.g., personnel and equipments). Cases
with subdiagnostic DTS images (7 patients) were included
in the calculation of costs. We did not calculate any unit cost
by dividing the fixed cost of capacity resources by the total
number of imaging examinations for each technqiue. Better,
we considered the support capacity management since every
single examination does not require more time and costs
whether the number of examinations decreases. There is no
waste of capacity since other CT scans for other clinical
reasons are actually performed in the place of those chest
CT scans considered not necessary because of DTS.
The break even point for the DTS investment was calcu-
lated as:
Capacity (fixed) cost/unit contribution margin
where the capacity cost was the additional cost for the
Volume RAD software while the unit contribution mar-
gin=reimbursement rate - variable unit cost.
If the variable unit cost is zero as in the case of DTS,
the breakeven point is equal to the:
Fixed cost/reimbursement rate.
The depreciation cost of the employed fixed assets
(or technology costs) is calculated on a straight-line
basis. The basic value for the depreciation corresponds to
the historical cost of the equipment. The useful life of the
radiological equipments for the economic analysis is
considered 10 years, which include both their technolog-
ical obsolescence and the clinical effectiveness [15]. The
maximum practical capacity may be considered equal to
that of the personnel by accepting that the fixed assets
Table 1 Confidence scoring system
Confidence score Reader finding
1 or 2 Definite or probable
(1) Benign pulmonarya or extrapulmonary lesionb
(2) Pulmonary pseudolesionc
3 Indeterminated
4 or 5 Probable or definite pulmonary lesione
Diagnostic confidence scoring system
aCentrally calcified pulmonary lesions or pulmonary lesions with gross
calcifications or calcified fibrotic scars with pulmonary architectural
distortion
b Lesions not contained in the limits of lung parenchyma (e.g. pleura or
thoracic wall) with or without calcifications
c Opacity not due to a true pulmonary or extra-pulmonary lesions but to
normal anatomical structures including composite areas of increased
opacity due to overlap of vascular and bone structures of the thoracic
wall, vascular kinking, anatomic variant, or also to rib fracture, bone
island or osteophytes
d Readers failed to classify confidently the presence of a lesion or whether
a lesion was pulmonary or extra-pulmonary or was a pseudolesion
e A solid pulmonary lesion, a parenchymal or ground-glass opacity, or a
solid or subsolid ground-glass pulmonary nodule
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used by the hospital have an embedded waste due to the
absence of availability of the personnel for the whole day.
In our case we have considered 2,600 h of maximum
practical capacity per year for the CXR and DTS units,
and 3,030 h per year for CT. The maintenance costs were
the current costs of 2012.We calculated the variable costs
related to the quality and quantity of the materials con-
sumed (contrast agents, disposable devices, etc.) and of
the services (e.g., electric energy) for the use of radiolog-
ical equipment employment. They were valued at direct
cost. For CT we performed separate calculations for
unenhanced CT and contrast-enhanced CT.
Statistical analysis
Statistical analysis was performed with a computer software
package (Analyse-it, version 1.63, Analyse-it-software,
Leeds, UK). A per-patient analysis was performed with the
marker lesion considered for the calculation of sensitivity,
specificity, positive and negative predictive values, and over-
all diagnostic accuracy.
To assess the improvement in observers’ performance in
correctly diagnosing pulmonary lesions, McNemar’s test [23]
was employed for sensitivity, specificity, and positive and
negative predictive values and the chi-square test with Yates
correction [23] for accuracy. The improvement in diagnostic
confidence was assessed by receiver-operating characteristic
(ROC) curve analysis by plotting the sensitivity (true-positive
fraction) against 1-specificity (false-positive fraction). The
area under each ROC curve was calculated by using a non-
parametric method [24], and the method proposed by Hanley
Fig. 1 a-eA 60-year-old man with a suspected pulmonary lesion on the
right lung. a Posteroanterior chest radiography in the upright position
shows one suspected pulmonary nodule in the right lung (arrow). b-d
Digital tomosynthesis images show the existence of a true lung opacity
(arrow). eCT confirms the pulmonary opacity in the right lung (arrow)
Table 2 Imaging pattern of lesions




Pulmonary opacities 60 2.5±0.3 2 - 3
Primary lung neoplasmsa 5 2.5±0.7 2 - 3
Ground-glass opacities/nodulesc 47 2.5±0.4 2 - 3
Non-calcified solid nodulesd 32 1.1±0.3 0.5 – 1.5
Pulmonary scarsb 26 1.1±0.3 0.5 - 1.5
Calcified solid nodules 23 1.1±0.3 0.5 – 1.5
Pleural plaques 36 2.4±0.6 1 - 3
Pulmonary pseudolesions ‡ 236 - -
Total number 465 2.3±1.1 0.5 - 4
Radiographic patterns of lesions included in the present study according
to reference standards
‡Includes composite areas of increased opacity resulting from overlap of
vascular and bone structures of the chest (n=129 patients), vascular
kinkings (n=55), prominent cardiac auricula (n=32) or anatomical lung
variants as accessory fissures (n=20)
a Lung adenocarcinomas proven by histology and corresponding to a
focal mass opacity with irregular or spiculated margins, and/or scissure
or pleural or vessel infiltration on CT
bAreas of parenchymal bands with architectural distortion due to fibrosis
with or without gross calcifications
c Ground-glass pattern as observed on CT, including two indolent lung
adenocarcinomas proven by biopsy
d Includes two lung adenocarcinomas proven by histology
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and McNeil [25] was employed to compare the areas under
each ROC curve.
The weighted κ statistic was calculated to assess
intra- and inter-group observer agreement [26]. Agree-
ment was graded as poor (κ value <0.20), fair (≥ 0.20
and<0.40), moderate (≥ 0.40 and<0.60), good (≥ 0.60
and<0.80) and very good (≥ 0.8 up to 1). The reader
interpretation time for CXR and DTS was compared by
Wilcoxon’s signed rank test. For all statistical tests, a P
value<0.05 was considered to indicate a statistically
significant difference.
Results
Based on reference standards, a total number of 229 thoracic
lesions, 193 pulmonary (Fig. 1) and 36 pleural, in 229/465
patients and 236 pseudolesions in the remaining 236/465
patients were included in the present study (Table 2).
Table 3 reports the different values of diagnostic perfor-
mance and confidence for CXR and DTS. CXR vs. DTS
differed in sensitivity, specificity, positive and negative pre-
dictive values, and overall diagnostic accuracy and area under
ROC curve for both readers. Inter-reader agreement improved
Table 3 Diagnostic performance and confidence
CXR DTS
a
Reader 1 Sensitivity (%) 24 (34/144) 80 (116/144)
Specificity (%) 10 (33/321) 95 (308/321)
Accuracy (%) 15 (69/465) 91 (424/465)
Diagnostic confidence:
Number TP TN FP FN Number TP TN FP FN
Score 1 1 / 1 / / 295 / 295 / /
Score 2 35 / 32 / 3 15 / 13 / 2
Score 3 379 / / 303 73 17a / / 10 7
Score 4 46 34 / 12 / 51 32 / 19 /
Score 5 4 0 / 4 / 87 84 / 3 /
(AUC) (95 % CI) 0.571 (0.525–0.616) 0.948 (0.924–0.967)
b
Reader 2 Sensitivity (%) 17 (25/144) 85 (122/144)
Specificity (%) 13 (43/321) 95 (308/321)
Accuracy (%) 17 (78/465) 92 (430/465)
Diagnostic confidence:
Number TP TN FP FN Number TP TN FP
FN
Score 1 2 / 1 / 1 297 / 296 /
Score 2 45 / 42 / 3 13 / 12 /
Score 3 386 / / 304 82 17a / / 11
Score 4 31 25 / 6 / 31 22 / 9
Score 5 1 0 / 1 / 107 102 / 5
(AUC) (95 % CI) 0.612 (0.566–0.656) 0.947 (0.923–0.966)
Visual prospective analysis in the pulmonary lesion diagnosis
The confidence scoring system is reported in Table 1
-CXRchest radiography;DTSdigital tomosynthesis; TP true positive [lesion correctly assessed as a non-calcified pulmonary lesion (confidence score 4 or 5)
or a lesion appearing as a parenchymal or ground-glass opacity, or a solid or subsolid ground-glass pulmonary nodule]; TN true negative (benign pulmonary
lesion-centrally calcified lesion or lesion with gross calcifications or calcified fibrotic scars with pulmonary architectural distortion-or extra-pulmonary lesion
or as a pulmonary pseudolesion; confidence levels 1, 2); FP false positive (benign pulmonary or extra-pulmonary lesion, or a pulmonary pseudolesion
incorrectly assessed as a pulmonary lesion) (confidence levels 4 or 5) or assessed as indeterminate (confidence score 3); FN false negative (pulmonary lesion
which should deserve further CTassessment assessed as an overt benign pulmonary lesion or pseudolesion or extrapulmonary lesion) (confidence levels 1 or
2) or assessed as indeterminate (confidence score 3); NPV negative predictive value; PPV positive predictive value. AUC area under the receiver-operating
characteristic curve; CI confidence interval
Sensitivity was defined as TP/(TP+FN); specificity, as TN/(TN+FP): accuracy, as. (TP+TN)/(TP+TN+FP+FN)
All differences between chest radiography and digital tomosynthesis were statistically significant (P<0.05)
a Including 7 (reader 1) or 6 (reader 2) solid subpleural pulmonary lesions and 10 (reader 1) or 11 (reader 2) pseudolesions
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from moderate with CXR (κ values=0.40) to very good with
DTS (κ value=0.89). After resolution of discrepant interpre-
tations between the two readers, chest CT examination
was performed in 127/465 (27 %) patients while in the
remaining 338/465 patients (73 %) CXR doubtful find-
ings were resolved by DTS.
Based on DTS images, readers correctly classified all
pseudolesions except for 10/236 (reader 1) or 11/236 (reader 2)
pseudolesions and 7 (reader 1) or 6 (reader 2) pulmonary
subpleural lesions (appearing as nodules or opacities both on
CXR and DTS) in which they were not able to classify confi-
dently whether a lesion was pulmonary or extra-pulmonary.
Those subpleural lesions were located in the anterior
or posterior region of the lung parenchyma in the prox-
imity of the thoracic wall.
The mean interpretation time for DTS (103 ± 66 seconds;
47–290 seconds) was higher (P<0.05) than for CXR (66 ± 23
seconds; 38–104 seconds).
Table 4 reports the equipment price, annual depreciation
and maintenance costs.
Table 5 reports the CXR, DTS and CTunit full costs. In the
year before DTS implementation, 811 patients who presented
suspected thoracic lesions underwent 271 CTs with an esti-
mated annual cost of €17,709.85 for unenhanced CT and
€30,801.86 for contrast-enhanced CT.
During the 12 months after DTS implementation, patients
who presented suspected thoracic lesions underwent 91 CXR,
130 DTS and 39 CT with an estimated annual cost of
€9,619.65 for unenhanced CT and 11,503.74 for contrast-
enhanced CTconsidering also the 7 subdiagnostic DTS. Thus,
the annual cost saving for the hospital with DTS is €8,090.2
considering unenhanced CT and €19,298.12 considering
contrast-enhanced CT.
Considering that the reimbursement rate for DTS is
€62.7 in our region and the variable costs are null for
DTS, the breakeven point corresponds to 479 DTS
examinations.
Discussion
Numerous methods have been proposed to address perceptual
limitations in CXR including dual-energy chest radiography,
bone subtraction and computer-aided diagnosis (CAD), and
these methods have experienced varying levels of success.
One of the most recent and promising technological advance-
ments for improving the diagnosis of subtle lesions in the
chest is DTS [7–9, 18]. In comparison to CXR, DTS produces
superior images for identifying the intra- or extrapulmonary
lesions previously suspected based on initial CXR interpreta-
tion. The major advantages of DTS over conventional CXR
are the removal of overlying anatomical structures, the en-
hancement of local tissue separation and availability of depth
information of the structure of interest [5–7].
In this study DTS was confirmed to be decisive in
confirming or ruling out pulmonary lesions and differentiating
true pulmonary opacities from those due to pleural or thoracic
wall lesions or pulmonary pseudo-lesions with a clear im-
provement in diagnostic accuracy, confidence and inter-
reader agreement in comparison to CXR and with a modest
increase in the radiation dose and interpretation time. This
presents a strong clinical impact, since up to 20% of suspected
nodules on CXR can be entities mimicking a solitary nodule
[27]. In our series, we found an even higher percentage of
pulmonary pseudolesions (50 %) leading the patients to
DTS. According to these results, DTS could be proposed
as a problem-solving technique in the diagnosis of those
Table 5 Unit full costs (€) for the different imaging modalities
Contrast agent Medical personnel Radiographers Nursing Asset depreciation Total cost
CXR 0 11,65 3,05 0 0,45 15,15
DTS 0 23,04 7,92 0 10,59 41,55
Unenhanced CT 0 31,95 7,07 6,98 19,35 65,35
Contrast-enhanced CT 25,83a 46,24 11,19 11,05 19,35 113,66
Costs are expressed in €
The mean unit occupation time was 6 min (range, 4-9 min) for chest radiography, 13 min (range 9–16 min) for digital tomosynthesis, 15 min (range 11–
16 min) for unenhanced computed tomography and 19 min (range, 15–22 min) for contrast-enhanced computed tomography
a Intended for 100 ml of contrast agent. €25.83 derives from the mean of €25.62 for iomeprol 350 and of €26.05 for iopromide 370
Table 4 Full costs of the different equipments




DTS 30,000a 3,750 10,000
CT 1,242,000 155,250 105,996
Costs are expressed in €
DTS digital tomosynthesis; CTcomputed tomography
a The cost includes the price for the VolumeRAD software, which should
be added to the x-ray equipment including the flat panel detector and the
x-ray tube
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suspected pulmonary lesions identified at the preliminary
assessment of CXR.
In this study we showed that the per-patient diagnostic
imaging costs decreased after DTS implementation in patients
with suspected thoracic lesions. Mainly, this result was due to
the dramatic effect of DTS on the CT utilisation rate that
decreased significantly after DTS implementation. In fact,
DTS resolved doubtful CXR findings for 338/465 (73 %)
patients, reducing the need for CT to only 27 % (127/465)
of patients. Once a chest opacity is suspected as being a solid
pulmonary lesion by DTS, it should then go to CT for further
evaluation, classification and staging. Lower CT utilisation
translated into less radiation exposure for patients and to the
availability of the CT unit for other examinations [28]. Ac-
cording to these results, DTS may be considered a first-line
problem-solving imaging technique to rule out pulmonary
lesions. Low-radiation-dose chest CT [28] could represent
an alternative imaging modality, even though it appears more
suitable for lung cancer screening [28–31], while the
advantage of DTS is the verification of doubtful findings
directly in the X-ray unit without moving the patient to
CT and with a comparable effective dose to CXR and
low-radiation-dose CT.
Compared to CT, the main limitation of DTS is the limited
depth resolution caused by the limited tomographic sweep
angle. Indeed, the resolution of DTS along the z-axis for chests
may be approximated to 2 mm [32]. In our series, all findings
misinterpreted at DTS were sub-pleural or located in the
region of the lung in the proximity of the chest wall, where
the limited depth resolution of DTS may hamper the correct
spatial location of the findings. This limitation is related to the
geometric frontal plane acquisition by DTS, since acquisition
in the sagittal plane is not recommended because of the higher
dose exposure [7, 8, 32].
DTS is a fast imaging technique that offers a clear improve-
ment in diagnostic accuracy and confidence over CXR, with a
much lower radiation dose than CT [28]. For the radiologist,
DTS studies took longer to read than CXR mainly because of
multiple image scrolling but the overall interpretation time
was lower than CT because of the lower number of images
evaluated. Even though DTS increased the interpretation time
[28], it could be easily introduced in the routine diagnostic
work flow as a case-solving technique in those patients with
suspected or equivocal pulmonary lesions on CXR.
All costs were calculated based on a single hospital and are
not necessarily transferable to other settings because of the
difference in valued added tax (VAT) and personnel wages in
our country. DTS could be interesting in de-centralised setting
(e.g., northern European countries) where small sites would
not have a CT scanner. In this case a digital x-ray unit could
allow a further sparing by clarifying unclear pulmonary le-
sions without having the patient travelling far to the next
centre with CT equipment. According to our findings,
considering the fixed cost due to the Volume RAD software
added to the digital detector and x-ray tube, the breakeven
point for the DTS investment corresponds to 479 DTS exam-
inations, which roughly corresponds to the number of patients
included in the present series.
The principal limitation of our study was the inclusion of a
heterogeneous group of patients who underwent CXR for
different clinical reasons. The inclusion of a more selected
patient cohort, e.g., patients with suspected pulmonary nod-
ules or patients with a known primary tumour and suspected
lung metastases, could provide further insights into the diag-
nostic accuracy and cost analysis of DTS. A second limitation
is due to the absence of blinded evaluation of CXR and DTS
images, since this prospective study was part of routine med-
ical care. The third limitation is the presence of multiple
reference standards including CXR for pseudolesions or overt
benign lesions, and CT or histology for positive pulmonary
lesions. This is because we decided to spare those patients
who did not present any finding deserving further imaging
workup on DTS from at CT dose and because this actually
represents what usually happens in routine clinical practice.
In conclusion, DTS avoided the need for chest CT in
about three-quarters of patients with suspected pulmonary
lesions on CXR. Per-patient diagnostic imaging costs
decreased after DTS implementation in patients with
suspected thoracic lesions.
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